Life Sciences

At Jacobs, we’re working toward a better future – for us all.


Together We Transform

For more than 70 years, Jacobs has assembled the best teams on the planet to overcome challenges no one else can. With a laser-like focus on innovation, we partner with the world’s leading Life Sciences firms to advance transformative treatments and therapies. We design, build, qualify and commission leading-edge, manufacturing facilities that positively impact people’s lives and shape a better tomorrow.

Together We Transform

Jacobs Senior Electrical Engineer Kevin Lee shares how his work directly impacted his family when his mom needed a drug product that was manufactured in the same facility he worked on – a reminder of how the work we do truly makes a difference.

  • 100 +

    life sciences projects, representing $50B+ in construction costs

  • 4 K+

    global resources

  • 20

    ISPE Facility of the Year Awards since 2010

  • # 1

    ENR Overall & Design Firm Global and Pharmaceuticals

Our Solutions

We’re supporting our biopharma clients to bring innovative products to market at pace. With a relentless focus on safety, quality and cost, our diverse, global teams and Subject Matter Experts (SMEs) deploy an integrated project delivery (IPD) approach and leverage cutting-edge digital tools to deliver ‘first of a kind’ facilities within accelerated timelines. In this rapidly evolving environment, we’re supporting clients to deliver projects in these emerging areas:

  • iStock-1310024666

    Messenger RNA (mRNA)

    mRNA is a rapidly evolving area of medicine with huge potential. United by a sense of shared purpose, we’re working with our biopharma clients, deploying creative thinking and high-level problem solving to accelerate the development and delivery of potentially transformative treatments.  The delivery of facilities that are designed for higher production volumes and make treatments accessible to more patients is a crucial step towards revolutionizing modern medicine.

  • iStock-1395265366

    Cell Therapy

    As the commercialization of autologous cell-therapy products gathers pace, wider access is becoming a reality. To ensure more people around the world can access these innovative treatments, we are partnering with clients to overcome operational and regulatory challenges as they scale out production.

  • iStock-1293619871

    Gene Therapy

    With an increasing number of cell and gene therapy products receiving regulatory approval, there is a burning need to deliver projects that support the growth of groundbreaking treatments. We’re working hand-in-hand with clients to provide a flexible approach to facility design that addresses complex challenges as manufacturers ramp up production capacity.

  • iStock-1090255620


    Contract development and manufacturing organizations (CDMOs) are supporting a seismic shift in Life Sciences, with their highly flexible large-scale facilities increasing production capacity on a massive scale, reducing risk for pharma companies, and guaranteeing hyper-speed project delivery. We’re helping CDMO clients reach these previously unattainable production targets with a flexible approach realized using integrated project delivery (IPD).

  • iStock-1368058797

    Flexible Facilities

    Flexibility played a central role in the response to COVID-19, with solutions providers and Life Sciences companies working together at lightning speed to retro-fit existing facilities for vaccines and treatments. This approach is helping to futureproof the sector, enabling companies to scale manufacturing in response to evolving patient needs, providing fast-tracked access to potentially transformative medicines treatments and therapies for patients globally and addressing patient demand for new treatments and therapies.

  • 1x1 white pixel

“Every day when I go to work, I’m focused on the fact that we’re all doing this for the patients. The facilities that we design and build on behalf of clients will produce medicine that may ultimately save lives.”

Julie Vickers headshot

Julie Vickers

Jacobs Subject Matter Expert & Lead Process Engineer

Meet the Team Transforming Life Sciences

Read more about the talent who make it happen every day.

Interested in working with Jacobs?

We’re always looking for dynamic and engaged people to join our team. Bring your passion, your ingenuity and your vision. 

external Explore career opportunities with us

Featured Projects

Our work continues to positively impact millions of lives with significant projects and programs around the globe.

“The transformative nature of the treatments and therapies our clients manufacture means our team is deeply invested and passionate about the work we do. This sense of purpose is embedded in every project we deliver. We’re united in our commitment to making sure more patients around the world gain access to life-enhancing medicines.”

John Noble

John Noble

Jacobs Vice President and General Manager Life Sciences

Want more life sciences projects?

Explore more Jacobs projects

From our newsroom

In the media

Overcoming Operational and Regulatory Challenges in Autologous Cell-Therapy Facilities

Francesca McBride - 203x135

Manufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing. Jacobs' Francesca McBride covers this topic in Pharmaceutical Technology.

Engineering Angles: A flexible future
Brian Ribnicky

Jacobs' Brian Ribnicky shares his thoughts on overcoming operational challenges in cell and gene therapy production in Pharma Manufacturing.

Engineering Angles: Fast-tracking access to treatments

How are How CDMOs are supporting a paradigm shift in pharma manufacturing? Jacobs' John Noble discusses with Pharma Manufacturing.

Achieving the ‘design one, build many’ paradigm

Jacobs' John Noble discussed how diversity and digitization can help fast-track CDMO projects with Pharma Manufacturing.

Designing Flexible Fill/Finish Facilities

Scenario modeling informs planning for current and future manufacturing needs. Jacobs' Jorge Ferreira and Lora Zeanchock discuss this concept and more in BioPharm International.

Fujifilm picks Jacobs Engineering for $2B Holly Springs Project

Rendering of Fujifilm Diosynth's large-scale cell culture production site. FUJIFILM DIOSYNTH

Triangle Business Journal provides details on Jacobs' selection by Fujifilm for its new project.

Rendering courtesy of FUJIFILM DIOSYNTH

Controlling Quality in Aging Facilities


Manufacturing biopharmaceuticals in an aging facility may create quality issues such as equipment breakdown and contamination risks. BioPharm International explores this topic.



Together, We Transform


Jacobs' John Noble shares how Jacobs' Life Sciences team operates at the cutting edge of science and technology to help save lives.


How The Bio-pharma Sector’s Quest to Combat COVID-19 is Transforming Project Delivery


Jacobs' John Noble shares a winning formula for project delivery in the age of accelerated project delivery.


“I was part of a team that conducted engineering and homogeneity studies to ensure that the drugs being manufactured at a client facility complied with the exact same high standard. I could never have imagined how much those drugs would one day change my life. Every time I think about the projects I work on; I am overcome with an overwhelming sense of pride. It’s a real-life reminder of how much our work positively impacts lives, including our own.”

Kevin Lee

Kevin Lee

Jacobs Senior Electrical Engineer


When it comes to health systems and life sciences, we'll provide our best care so you can provide yours. 

Explore our health & life sciences market